William Lewis - Mar 23, 2022 Form 4 Insider Report for INSMED Inc (INSM)

Role
Chair and CEO, Director
Signature
/s/ William H. Lewis, by Michael Smith as Attorney in Fact
Stock symbol
INSM
Transactions as of
Mar 23, 2022
Transactions value $
-$734,777
Form type
4
Date filed
3/25/2022, 05:40 PM
Previous filing
Jan 13, 2022
Next filing
May 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Options Exercise $430K +30.2K +13.89% $14.24 248K Mar 23, 2022 Direct F1
transaction INSM Common Stock Sale -$700K -30.2K -12.2% $23.16 218K Mar 23, 2022 Direct F1, F2
transaction INSM Common Stock Options Exercise $1.06M +65.4K +30.05% $16.16 283K Mar 23, 2022 Direct F1
transaction INSM Common Stock Sale -$1.51M -65.4K -23.11% $23.16 218K Mar 23, 2022 Direct F1, F3
transaction INSM Common Stock Options Exercise $15.9K +981 +0.45% $16.16 219K Mar 23, 2022 Direct F1
transaction INSM Common Stock Sale -$23.2K -981 -0.45% $23.61 218K Mar 23, 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Options Exercise $0 -30.2K -100% $0.00* 0 Mar 23, 2022 Common Stock 30.2K $14.24 Direct F5
transaction INSM Stock Option (right to buy) Options Exercise $0 -65.4K -40.13% $0.00 97.6K Mar 23, 2022 Common Stock 65.4K $16.16 Direct F5
transaction INSM Stock Option (right to buy) Options Exercise $0 -981 -1.01% $0.00 96.6K Mar 23, 2022 Common Stock 981 $16.16 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2 This is the weighted average sales price representing 30,228 shares sold at prices ranging from $22.62 to $23.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3 This is the weighted average sales price representing 65,405 shares sold at prices ranging from $22.61 to $23.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4 This is the weighted average sales price representing 981 shares sold at prices ranging from $23.61 to $23.64 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5 The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.